BioSpace News Archive

ArunA Biomedical today announced that Steven Stice, Ph.D., co-founder, chief executive and chief scientific officer, will present a corporate update and participate on a panel at the 2018 BIO International Convention occurring June 4-7, 2018 in Boston, MA.

For the first time, BioPharmX will share its research at the Congress of Clinical Dermatology

Schweiger Dermatology Group (“SDG”), the largest and fastest-growing dermatology practice management company in the Northeast, has announced today that it received an investment of $100 million from LNK Partners, a private equity firm with a long track record of investing in outstanding consumer businesses.

Clinical trial extends previous studies of SPL-108 in ovarian cancer

Vizient, Inc., continued to demonstrate growth and high member retention by announcing that it had closed 26 new, renewed or expanded agreements with health care organizations in the last quarter of 2017.

An abstract of the article, titled ‘A randomised, open-label, parallel group phase 2 study of antisense oligonucleotide therapy in acromegaly,’ is currently available online

Newly Created Positions of Senior Vice President, Corporate Strategy, Communication & Finance and Senior Vice President, Program Management and Product Planning

Teleflex will acquire the Company’s commercial coronary products and an option to purchase the drug coated Chocolate Heart™